SARCode Secures $44,000,000 Series B Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ea0191f3-3ced-462d-8859-a47306d4aa62&Preview=1 -
Date
7/18/2011 -
Company Name
SARCode -
Mailing Address
1000 Marina Boulevard Brisbane, CA 94005 -
Company Description
SARcode is a private, San Francisco based company focused on the development of small molecule LFA-1 inhibitors to treat inflammatory diseases. -
Website
http://www.sarcode.com -
Transaction Type
Venture Equity -
Transaction Amount
$44,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds from the Series B financing will largely support further clinical development of SAR 1118, SARcode’s lead compound for the treatment of dry eye syndrome. -
M&A Terms
-
Venture Investor
Sofinnova Ventures -
Venture Investor
Rho Ventures -
Venture Investor
Alta Partners -
Venture Investor
Clarus Ventures
